Dr. Carlos Buznego Transforming Treatment of Glaucoma with iStent
Cataract Surgery Miami,Glaucoma Miami,Uncategorized
On June 25th, 2018, Glaukos Corporation announced it received premarket approval (PMA) from the FDA for the iStent inject® Trabecular Micro-Bypass System. The iStent inject® is indicated for the reduction of intraocular pressure (IOP) in adult mild-to-moderate primary open-angle glaucoma (POAG) patients who are also undergoing cataract surgery. In order to achieve their goal of transforming the…
Read More
